82 related articles for article (PubMed ID: 34644781)
1. Anticancer effects of 6-shogaol via the AKT signaling pathway in oral squamous cell carcinoma.
Huang H; Kim MO; Kim KR
J Appl Oral Sci; 2021; 29():e20210209. PubMed ID: 34644781
[TBL] [Abstract][Full Text] [Related]
2. POLE2 Regulates Apoptosis of Oral Squamous Cell Carcinoma Cells through the PI3K/AKT Signaling Pathway.
Sun MY; Wang L; Shen ZY
Curr Med Sci; 2023 Dec; 43(6):1162-1172. PubMed ID: 38079056
[TBL] [Abstract][Full Text] [Related]
3. 6-Shogaol from ginger shows anti-tumor effect in cervical carcinoma via PI3K/Akt/mTOR pathway.
Pei XD; He ZL; Yao HL; Xiao JS; Li L; Gu JZ; Shi PZ; Wang JH; Jiang LH
Eur J Nutr; 2021 Aug; 60(5):2781-2793. PubMed ID: 33416981
[TBL] [Abstract][Full Text] [Related]
4. Role of Stromal Fibroblast-Induced WNT7A Associated with Cancer Cell Migration Through the AKT/CLDN1 Signaling Axis in Oral Squamous Cell Carcinoma.
Kayamori K; Katsube KI; Hirai H; Harada H; Ikeda T
Lab Invest; 2023 Oct; 103(10):100228. PubMed ID: 37541622
[TBL] [Abstract][Full Text] [Related]
5. The antitumor effects of herbal medicine Triphala on oral cancer by inactivating PI3K/Akt signaling pathway: based on the network pharmacology, molecular docking, in vitro and in vivo experimental validation.
Hu S; Li S; Xu Y; Huang X; Mai Z; Chen Y; Xiao H; Ning W; Gaus S; Savkovic V; Lethaus B; Zimmerer R; Acharya A; Ziebolz D; Schmalz G; Huang S; Zhao J; Hu X
Phytomedicine; 2024 Jun; 128():155488. PubMed ID: 38493718
[TBL] [Abstract][Full Text] [Related]
6. Anticancer effects of gossypetin from Hibiscus sabdariffa in oral squamous cell carcinoma.
Huang K; Liu Z; Kim MO; Kim KR
J Appl Oral Sci; 2023; 31():e20230243. PubMed ID: 37820185
[TBL] [Abstract][Full Text] [Related]
7. Effects of IGF-1 on Proliferation, Angiogenesis, Tumor Stem Cell Populations and Activation of AKT and Hedgehog Pathways in Oral Squamous Cell Carcinoma.
Ferreira Mendes JM; de Faro Valverde L; Torres Andion Vidal M; Paredes BD; Coelho P; Allahdadi KJ; Coletta RD; Souza BSF; Rocha CAG
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899449
[TBL] [Abstract][Full Text] [Related]
8. Silencing POLE2 promotes apoptosis and inhibits proliferation of oral squamous cell carcinomas by inhibiting PI3K/AKT signaling pathway.
Ge S; Wang K; Meng Y; He Z; Yang X; Shang W; Wang L
Med Oncol; 2023 Sep; 40(10):304. PubMed ID: 37733085
[TBL] [Abstract][Full Text] [Related]
9. The role of phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (PAG1) in regulating the progression of oral squamous cell carcinoma.
Sun Y; Yang X; Guan S; Ma T; Jiang Z; Gao M; Xu Y; Cong B
Arch Oral Biol; 2023 Dec; 156():105810. PubMed ID: 37852106
[TBL] [Abstract][Full Text] [Related]
10. FSCN1 promotes proliferation, invasion and glycolysis via the IRF4/AKT signaling pathway in oral squamous cell carcinoma.
Li L; Chen L; Li Z; Huang S; Chen Y; Li Z; Chen W
BMC Oral Health; 2023 Jul; 23(1):519. PubMed ID: 37491232
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome and proteomics conjoint analysis reveal metastasis inhibitory effect of 6-shogaol as ferroptosis activator through the PI3K/AKT pathway in human endometrial carcinoma in vitro and in vivo.
Ma RH; Ni ZJ; Thakur K; Cespedes-Acuña CL; Zhang JG; Wei ZJ
Food Chem Toxicol; 2022 Dec; 170():113499. PubMed ID: 36341865
[TBL] [Abstract][Full Text] [Related]
12. Enhanced lipid biosynthesis in oral squamous cell carcinoma cancer-associated fibroblasts contributes to tumor progression: Role of IL8/AKT/p-ACLY axis.
Liu P; Wang Y; Li X; Liu Z; Sun Y; Liu H; Shao Z; Jiang E; Zhou X; Shang Z
Cancer Sci; 2024 May; 115(5):1433-1445. PubMed ID: 38494608
[TBL] [Abstract][Full Text] [Related]
13. Imatinib inhibits oral squamous cell carcinoma by suppressing the PI3K/AKT/mTOR signaling pathway.
Ma L; Huang K; Zhang H; Kim E; Kim H; Liu Z; Kim CY; Park K; Raza MA; Kim K; Yi J; Sung Y; Ryoo ZY; Kim YG; Kim MO
J Cancer; 2024; 15(3):659-670. PubMed ID: 38213733
[TBL] [Abstract][Full Text] [Related]
14. Costunolide Induces Apoptosis via the Reactive Oxygen Species and Protein Kinase B Pathway in Oral Cancer Cells.
Huang H; Yi JK; Lim SG; Park S; Zhang H; Kim E; Jang S; Lee MH; Liu K; Kim KR; Kim EK; Lee Y; Kim SH; Ryoo ZY; Kim MO
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299129
[TBL] [Abstract][Full Text] [Related]
15. Potential targets of diosgenin for the treatment of oral squamous cell carcinoma and their bioinformatics and transcriptional profiling analyses.
Xiao Y; Xu B; Li X; Ding T; Zhao W; Nie X; Mu J; Xiao Z; Wang Q; Ren Q; Zhang E
Steroids; 2024 May; 205():109393. PubMed ID: 38458369
[TBL] [Abstract][Full Text] [Related]
16. Isoliquiritigenin Inhibits Oral Squamous Cell Carcinoma and Overcomes Chemoresistance by Destruction of Survivin.
Zhou Z; Han S; Liao J; Wang R; Yu X; Li M
Am J Chin Med; 2023; 51(8):2221-2241. PubMed ID: 37930332
[TBL] [Abstract][Full Text] [Related]
17. Protective Effect of Alpha-Linolenic Acid on Human Oral Squamous Cell Carcinoma Metastasis and Apoptotic Cell Death.
Su CC; Yu CC; Shih YW; Liu KL; Chen HW; Wu CC; Yang YC; Yeh EL; Li CC
Nutrients; 2023 Dec; 15(23):. PubMed ID: 38068849
[TBL] [Abstract][Full Text] [Related]
18. TCRP1 promotes radioresistance of oral squamous cell carcinoma cells via Akt signal pathway.
Gu Y; Fan S; Liu B; Zheng G; Yu Y; Ouyang Y; He Z
Mol Cell Biochem; 2011 Nov; 357(1-2):107-13. PubMed ID: 21603883
[TBL] [Abstract][Full Text] [Related]
19. 6-shogaol induces apoptosis and enhances radiosensitivity in head and neck squamous cell carcinoma cell lines.
Kotowski U; Kadletz L; Schneider S; Foki E; Schmid R; Seemann R; Thurnher D; Heiduschka G
Phytother Res; 2018 Feb; 32(2):340-347. PubMed ID: 29168275
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of COX-2, Ki-67, Bcl-2, Bax, VEGF and CD105 according to histological grading in oral squamous cell carcinoma.
Escobar E; Gómez-Valenzuela F; Peñafiel C; Hormazábal-Hevia A; Herrera-Fuentes C; Mori-Aliaga D
Rev Esp Patol; 2023; 56(3):147-157. PubMed ID: 37419553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]